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Unsafe abortion has been acknowledged as one of the major causes 
of maternal mortality and morbidity in Ghana. According to the 
2007 Ghana Maternal Health Survey report, 11% of the reported 451 
maternal deaths were abortion related (Macro International, 2009). 
With limited numbers of trained service providers and well equipped 
facilities to provide surgical abortions, medical non-surgical methods 
of terminating pregnancies promises an additional way of increasing 
access to safe abortion services as permitted by law and contributing to 
reducing maternal mortality and morbidity (Medical Abortion, 2009). 
To support the government’s effort in achieving MDG 5, in September 
2006, a consortium of five (5) agencies consisting of EngenderHealth, 
Ipas, Marie Stopes International - Ghana (MSIG), Population Council 
and Willows Foundation, in collaboration with the MOH/GHS and 
with funding from an anonymous donor, initiated a program  named 
Reducing Maternal Mortality and Morbidity (R3M). The program 
provides the commitment, financial and technical resources that 
enable the government to expand significantly women’s access to 
modern family planning and comprehensive abortion care (CAC) 
services. MSIG’s focus is in the provision of family planning and 
comprehensive abortion care services in the private sector. MSIG’s 
mandate also includes the piloting and registration of new technologies 
and procedures for abortion care management; a provisional license 
was awarded to MSIG by the Ghana Food and Drugs Board (FDB) for 
the introduction and provision of the first medical abortion regimen 
(Mifepristone and Misoprostol) in Ghana. Population Council 
conducted this study to document this introduction process, findings 
from the study will provide the much needed evidence based report to 
inform policy decision making and the scale-up phase.
The study involved a total of ten health facilities: (4) MSIG centers: 
Ashiaman and U-Compound in Tema, Kokomlemle in Accra and 
Kumasi and (6) public health facilities: Korle Bu Teaching Hospital, 
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Ridge and La General Hospitals in Greater Accra Region, Koforidua 
Regional and Oda Government Hospitals in Eastern Region and 
Manhyia Hospital in Ashanti Region.  The research team interviewed a 
total of 477 clients and 13 health providers. However, due to missing/
incomplete data 461 client and all 13 provider interview data was used 
for the preparation of this report.
The study aimed at documenting the introduction of the dual regimen; 
Mifepristone and Misoprostol for early pregnancy termination.  The 
study also examined health providers’ skills, quality of services 
delivered, and clients’ satisfaction with the method and provider-patient 
interpersonal rapport among others. The results show that the mean 
age of clients who sought medical abortion services was about 26 years. 
Thirteen (13) percent of all interviewed clients were teenagers between 
the ages of 15 and 19 years. The majority of clients (55%) had never 
been married while the average number of pregnancy experienced 
was about three (3). Eighty three (83) percent of the interviewed 
clients had at least completed primary education with about 24% still 
being students. Out of the providers interviewed, 10 were midwives, 
two (2) were general nurses and one was a medical assistant. Ninety 
two percent of all interviewed providers showed good and adequate 
knowledge in medical abortion service provision procedures, almost 
all, 12 out of 13 service providers knew the accurate and recommended 
dosage of Mediprist.
Results also revealed that about 50% of the clients who visited the 
facilities had medical abortion in mind whiles the rest had MVA/EVA 
in mind.  Approximately 93% of all the clients reported that in making 
a choice, they were provided with sufficient information on the two 
methods available. A total of 73% of all clients’ reasons for choosing 
medical abortion over surgical abortion was to avoid anesthesia, 
surgery, risk of complications and pain.     
After an initial dose of Mediprist, the reported expulsion time of the 
product of conception for over 80% of clients was within 24 hours 
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after administration of Misoprostol. For 16% of interviewed clients, 
complete expulsion occurred after 24 hours, to complete the expulsion 
process for the remaining four (4) percent of clients who had reported 
that the product of conception was not expelled, an additional dose 
of Misoprostol was given/surgical completion was done at no cost to 
them. 
The most common side effects mentioned were cramps and bleeding 
after the Mediprist and Misoprostol respectively, three in five clients 
used a pain medication during the process. 
Acceptability of medical abortion procedure was very high; about 81% 
of the clients indicated that they will use the method again if they had 
to, while about 90% indicated that they will recommend the method 
to their family and friends; approximately 85% of the providers were 
satisfied with the procedure. 
RECOMMENDATIONS
•	 Scale-up	is	encouraged	given	the	high	success	rate	with	the		 	
 medical abortion combined regimen at the study sites.
•	 Service	providers	need	to	be	given	a	thorough	orientation
 on medical abortion counseling and service provision.    
•	 Family	planning	counseling	should	be	a	major	part	of	the	
 follow up visit.
•	 Use	of	effective	contraceptive	method	should	be	strongly	
 encouraged to all clients. 
•	 Clients	need	to	be	given	adequate	information	about	the	






The term medical abortion refers to pregnancy termination with 
abortion-inducing medications in lieu of primary surgical intervention 
(Creinin, 2000).  Although the idea of using medications to induce 
abortion has been around for centuries, evidence-based regimens for 
use in the first trimester of pregnancy only became a reality in the last 
25 years. An estimated 22 unsafe abortions occur for every 1000 women 
globally. An alarming fifth of all maternal deaths in Africa are due to 
complications arising from unsafe abortions. With limited numbers 
of trained service providers and fully equipped facilities to provide 
surgical abortions, medical non-surgical methods of terminating 
pregnancies promises an additional way of increasing access to safe 
abortion services and contributing to reducing maternal mortality and 
morbidity.
Like most countries in sub-Saharan Africa, Ghana suffers from 
high maternal mortality and morbidity due partly to high rates of 
unwanted fertility and unsafe abortion and relatively low use of 
modern contraception. Although the Government of Ghana has made 
impressive gains in recent years, access to reproductive health services 
remains poor, particularly so for the majority of the population who 
live in rural, impoverished, and isolated communities. Only 17 percent 
of married women of reproductive age use modern contraceptive 
methods (Macro International 2009), and data from the 2008 Ghana 
Demographic and Health Survey indicates that 14 percent of all births 
in Ghana are unwanted, 37 percent are unplanned, and 23 percent 
are mistimed (Macro International 2009). Mistimed, unplanned, 
and unwanted fertility arise from limited access to and use of family 
planning services.
In Ghana abortion is a criminal offence regulated by Act 29, section 
58 of the Criminal code of 1960, amended by PNDCL 102 of 1985 
(Criminal Code of Ghana, 1960). It states that:
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1.   Subject to the provisions of subsection (2) of this section 
a. Any woman who with intent to cause abortion or   miscarriage 
administers to herself or consent to be administered to her any 
poison, drug or other noxious thing or uses any instrument or 
other means whatsoever; or
      b. Any person who
i.    Administers to a woman any poison, drug or other noxious 
thing or uses any instrument or other means whatsoever with 
intent to cause abortion or miscarriage, whether or not the 
woman is pregnant or has given her consent;
ii.   Induces a woman to cause or consent to causing abortion or 
miscarriage;
iii.   Aids and abets a woman to cause abortion or miscarriage;
iv.    Attempts to cause abortion or miscarriage; or
v.   Supplies or procures any poison, drug, instrument or other 
thing knowing that it is intended to be used or employed to 
cause abortion or miscarriage; shall be guilty of an offence and 
liable on conviction to imprisonment for a term not exceeding 
five years.
2.  It is not an offence under section (1) if an abortion or miscarriage  
is caused in any of the following circumstances by a registered medical 
practitioner specializing in gynecology or any other registered 
medical practitioner in a government hospital or a private hospital 
or clinic registered under the Private Hospital and Maternity Home 
Act, 1958 (No. 9) or in a place approved for the purpose by legislative 
instrument made by the Secretary: 
a. Where pregnancy is the result of rape or defilement of a female 
idiot or incest and the abortion or miscarriage is requested by 
the  victim or her next of kin or the person in loco parentis, if 
she lacks the capacity to make such request;
b. Where the continuance of the pregnancy would involve risk 
to the life of the pregnant woman or injury to her physical or 
mental health and such a woman consents to it or if she lacks the 
capacity to give such consent it is given on her behalf by her next 
of kin or the person in loco parentis;
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c. Where there is substantial risk that if the child were born 
it may suffer from or later develop a serious physical 
abnormality or disease.
3. For the purposes of this section Abortion or miscarriage means 
premature expulsion or removal of conception from the uterus or 
womb before the period of gestation is completed.
The above thus allow Ghanaian women the legal option to terminate 
an unwanted pregnancy.  Despite this “liberal” law, implementation 
of programs to match the policy intentions has been slow; moreover, 
knowledge of safe abortion services is also not widespread among 
communities.  Information gaps remain in key areas such as systematic 
documentation of the implementation of the law; the various service 
models for safe abortion services; methods for monitoring quality 
of care of services; technical resources and updated information of 
technologies and procedures.  
In 2006, a consortium of five agencies; EngenderHealth, Ipas, 
Marie Stopes International, Population Council, and the Willows 
Foundation came together to provide technical and financial support 
to the Government of Ghana in the provision of family planning and 
CAC services. The consortium collaborates with the Government 
of Ghana in expanding women’s access to modern family planning 
and comprehensive abortion care. The consortium’s program titled 
“Reducing Maternal Morbidity and Mortality” (R3M) program, aims 
to increase access to FP services and reduce unwanted pregnancy and 
severe complications and deaths caused by unsafe abortions. 
As part of the R3M program, Marie Stopes International Ghana 
(MSIG) is providing family planning and comprehensive abortion care 
services in the private sector. MSIG has established four static “centers 
of excellence” clinics, three in Accra and one in Kumasi. These centers 
provide a range of sexual and reproductive health services (SRH) at 
affordable prices. Part of MSIG’s mandate is to increase access to and 
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utilization of quality, sustainable CAC and FP services through the 
establishment of a network of franchised service delivery centers.  A 
total of 100 franchisees comprising 42 Clinics, 25 Pharmacy shops and 
33 Chemical sellers have been recruited and receive technical support 
and SRH commodities from MSIG. These franchisees also serve as 
referral points for the MSIG Centers.  MSIG’s mandate also includes 
the introduction of new technologies and procedures for abortion care 
and management.  
Mifepristone, branded by MSIG as MEDIPRIST, has been granted 
temporary approval and permission by the Ghana Food and Drugs 
Board (FDB) to be used as a medical abortifacient. Together with 
Misoprostol which has already been approved for use in Ghana 
by FDB, the two regimen combination will be used for the medical 
abortion procedure; an oral administration of 200mg Mifepristone 
(MEDIPRIST) ideally in the health facility followed by an oral 
administration of 800mg misoprostol 24-48 hours later either in the 
facility or any other place of choice for the woman. Complete approval 
will be granted primarily based on the outcome of this documentation 
process. The FDB registration process includes stringent measures for 
documenting usage; one registration condition was for the introduction 
to be channeled only through MSIG centers, franchisee clinics and 
selected GHS service delivery sites for an initial introductory period 
during which time the process will be documented. All providers in 
the implementation sites received training from MSIG, the training 
included an overview of the product information, including dose 
regimen, efficacy, side effects, contra-indications, counseling, and 
general norms and procedures for provision of medical abortion.
This study was undertaken by the Population Council as an unbiased 
evaluator, taking the lead role in the documentation process to 
objectively report on the introduction of the combination regimen 
Mediprist and Misoprostol as a Medical Abortifacient. The findings 
from this study will inform all stakeholders and lessons learnt will 




The primary objective of this study was to document the introduction 
of Mifepristone and Misoprostol for early  medical abortion in Ghana.
The specific objectives were to:
1. Assess the ability of providers and early experience of providers  in 
the provision of the new regimen;
2. Document the quality of care of abortion services offered at both 
private and public health facilities; 
3. Document client satisfaction with the medical abortion procedure;
4. Document all client side/adverse effects experienced;




The study population was women in their reproductive age (15 – 49 
years old) who sought abortion services from designated facilities in 
Accra, Ashanti and Eastern regions.  For a woman to be eligible for the 
study, she was expected to be in general good health and must have 
been assessed by a clinician to have an intrauterine pregnancy that 
was less than 49 days on the first day of contact with the study team. 
Only the clients who after counseling on the two available methods 
chose medical abortion were included in the study. The study used 
the following as criteria for selecting eligible women for the study. The 
woman must:
•	 Be	willing	to	participate,	consent	and	be	able	to	endorse	an	 	









The study considered women with any of the following conditions as 













The study was facility-based: four MSIG static centers in Kumasi and 
Accra; and six public health facilities, KBTH, Ridge and La General 
Hospitals in Greater Accra Region, Koforidua Regional Hospital and 
Oda Government Hospital in Eastern Region and Manhyia Hospital 
in Ashanti Region were the study sites. Inclusion of both public and 
private health facilities allowed for documentation of the process in the 
two settings where services will normally be provided and also provided 
a wide range of clients with different backgrounds and experiences.
As stated above, all women in the study received 200mg Mediprist orally 
at the facilities during the initial visit followed by an oral administration 
of 800mg misoprostol 24-48 hours later either in the facility or any 
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other place of choice for the client. All clients were required to return 
to the facilities in 10-14 days for a follow up examination to ensure 
complete expulsion, during this visit, clients will be counseled and 
provided with their choice of a family planning method to prevent 
future unintended pregnancies. As part of the initial counseling, the 
importance of the follow-up examination visit is stressed to clients 
and they are also provided with token funds to assist with their 
transportation expenses for the follow-up visit, a combination which 
allowed a high client return rate. Client exit interviews were conducted 
immediately after the completion of the examination during follow 
up visit. Service providers who offered medical abortion services were 
also interviewed. The study team included interviewers who were 
each assigned to each of the study sites for the duration of the study. 
The women were identified at first visit and then interviewed after 
they completed the review visit. Data collection was conducted over a 
period of 5 months. 
Study Findings 
Socio-Demographic and Economic Characteristics of Clients
The study interviewed 477 women in their reproductive age (15 – 49 
years old) across ten health care service delivery facilities in three 
administrative regions of Ghana namely Greater Accra, Ashanti and 
Eastern Regions. These ten health facilities comprise six tertiary care 
public health institutions; Koforidua Regional Hospital, KBTH, La 
General Hospital, Manhyia Government Hospital, Oda Government 
Hospital and Ridge Hospital; and 4 Marie Stopes International centers 
of excellence in Ashiaman, Kokomlemle, Manhean and Kumasi. 
The socio-demographic and economic characteristics of clients are 
shown in Appendix. About three out of five (58.9 percent) clients were 
residents of Accra, 11.7 percent resided in Kumasi and approximately 
4.5 percent were residents of Koforidua. The remaining 24.9 percent 
were residents of nearby communities around Accra, Tema, Kumasi 
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and Koforidua and others coming from Nsawam and Ofoase in the 
Eastern Region and as far as Bolgatanga in the Upper East.
A mean age of 25.8 years was reported among clients interviewed with 
13.2 percent in their teen years and the rest distributed across the other 
age groups (Table 1). More than half (55.0 percent) had never been 
married, 26.3 percent were married, 15.8 percent were in consensual 
unions (cohabiting) and the remaining three percent were widowed, 
divorced or separated. 
About six percent (6.3 percent) of the clients had no formal education, 
more than half (55.6 percent) had secondary or higher education 
and the rest had primary or basic education. The majority of clients 
interviewed, 89.5 percent were Christians and 8.6 percent were of the 
Islamic faith, the others belonged to a traditional religion or had no 
religion. About 49.2 percent of clients interviewed belonged to the 
Akan ethnic group while the rest were distributed among Ewe, Ga-
Dangme, Mole Dagbani, Guan, and other ethnic groups. About one in 
ten clients were unemployed with a little over a quarter (26.5 percent) 
employed in the professional/clerical/technical field, 23.6 percent were 
students and about twenty two percent were traders (22.3 percent). 
Fertility Experience of Clients Interviewed
The mean children ever born among the study sample is relatively 
lower than the mean number of pregnancies experienced. While the 
average number of children born (live birth) is approximately one 
child, the average number of pregnancies experienced is about three as 
seen in Table 1. The maximum number of pregnancies experienced by 
any client in our sample is 16 while the highest number of live births 
is 11 children. The average preferred number of children for our client 
sample is about three children. The table does highlight an interesting 
fertility behavior pattern worth noting, it shows that on average the 
clients have had 1.5 more pregnancies than live births, i.e. most women 
interviewed have had 1-2 abortions (or miscarriages) before this visit. 
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Yet, although on average they currently have 1 child, they would prefer 
to have at least 3 children.  A question which we do not address in 
this paper is why are these women having repeated abortions when the 
average preferred number of children and live births is three and one 
respectively?
Assessment of Medical Abortion Service Provision: 
Client Perspective
During the initial consultation with service providers on the various 
methods of pregnancy termination, almost nine in ten (88.7 percent) 
clients indicated that MVA/EVA was mentioned and discussed with 
them. Almost all (99.4 percent) indicated that the medical abortion 
process and eligibility requirements were discussed with them. About 
46 percent (212) of clients who came to the health facility had some 
particular pregnancy termination method in mind. Among these 
clients, about half (50.9 percent) had medical abortion in mind, about 
48.1 percent had termination by MVA/EVA in mind and the rest 
mentioned Cipro, D&C.
About 93.1 percent of the clients reported that they felt that the 
service providers gave sufficient information on available options for 
pregnancy termination during their first counseling consultation. The 
majority, 90.2 percent and 92.0 percent respectively indicated they had 
the opportunity to ask questions and chose a preferred method for 
their pregnancy termination. The distribution of the most important 
reasons for deciding to use medical abortion is shown in Table 2. The 
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Table 1: Pregnancies and Children Ever Born 
Variable Mean Min Max 
Std. 
Deviation Number 
Preferred  # of children  3.1 0 10 1.2 461 
Pregnancies 2.5 0 16 1.9 461 
Live birth 1.0 0 11 1.4 461 
Living children 0.9 0 8 1.3 461 
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method in mind. Among these clients, about half (50.9 percent) had medical abortion in 
mind, about 48.1 percent had termination by MVA/EVA in mind and the rest mentioned 
Cipro, D&C and shots “injection” which are all other forms of termination methods. 
 
About 93.1 pe cent of the clients rep rted that they felt that the service provid rs gave 
sufficient information on available options for pregnancy termination during their first 
counseling consultation. The majority, 90.2 percent and 92.0 percent respectively indicated 
they had the opportunity to ask questions and chose a preferred method for their pregnancy 
termination. The distribution of the most important reasons for deciding to use medical 
abortion is shown in Table 3. The most mentioned reason for deciding to use medical 
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Experience with the Medical Abortion Procedure
Clients visit the health facilities, they are first counseled on the available 
options and eligibility criteria. As part of the counseling for the 
medical abortion procedure, the clients are informed of the regimen, 
the mode(s) of administration of the medication(s) and are also told 
about the option to take the second medication, either at the facility 
or at home. All clients had the first drug, Mediprist administered at 
the clinic. As shown in Table 3, approximately 68 percent of the clients 
indicated that they would have preferred to take the Mediprist at the 
most mentioned reason for deciding to use medical abortion was to 
avoid surgery (31.2 percent), and to avoid physical trauma or pain (25.4 
percent). About one percent of the clients mentioned more than one 
reason for deciding to use medical abortion instead of surgical abortion.
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Table 2: Reasons for Selection of Medical Abortion 
Reasons  
Responses 
 Number Percent 
 To avoid surgery 144 31.2 
To avoid physical trauma/pain 117 25.4 
It is less risky/no complications 47 10.2 
It was recommended by a friend 41 8.9 
Was offered no other option 25 5.4 
It is less expensive 23 5.0 
To avoid anesthesia 16 3.5 
It is less invasive 10 2.2 
It is more effective 7 1.5 
Other reasons 14 3.0 
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When the clients visit the health facilities, they are first counseled on the available options 
and eligibility criteria. As part of the counseling for the medical abortion procedure, the 
clients are informed of the regimen, the mode(s) of administration of the medication(s) and 
are also told about the option to take the second medication, either at the facility or at home. 
Of the two medications, Misoprostol and Mediprist which were administered to clients, all 
had the first drug, Mediprist administered at the clinic. As shown in Table 4, approximately 
68 percent of the clients indicated th t they would hav  preferred to take the Misoprostol at 





Table 3: Location Preference for Mediprist Administration 
 
Responses 
 Preference Number Percent 
Clinic  313 67.9 
Home 129 28.0 
Not Terminate Again 11 2.4 
Indifferent 8 1.7 




Table 4: Location for Misoprostol Administration 
 
Responses 
 Preference Number Percent 
Clinic  280 60.7 
Home 181 39.3 
Total 461 100 
 
According to the interviewed clients, more than half (60.7 percent) of the them had the 
second drug, Misoprostol also administered at the clinic, with 39.3 percent taking the 
Misoprostol outside the clinic, 3 clients did not taking the Misoprostol. Table 5 shows the 
total number of clients who took Misoprostol outside the health facility. Out of this number, 
72 of them reported having someone with them when they took the medicine; Table 6 shows 
the distribution of the people who were present with the client. About 61 percent of the 
clients indicated having their partner present, 21 percent had their friends present when the 
drug was taken and only three percent of clients who took the Misoprostol outside the health 
facility had their mother present when they took the medication.  
clinic, with about 28 percent preferring to take it at home. 
 
More than half (60.7 percent) of clients interviewed had the second 
drug, Misoprostol also administered at the clinic, with 39.3 percent 
taking the Misoprostol outside the clinic, three clients did not take 
the Misoprostol. Table 4 shows the total number of clients who took 
Misoprostol outside the health facility. Out of t is number, 72 of them 
reported having someone with them when they took the medicine; 
Table 5 shows the distribution of the people who were present with the 
client. About 61 percent of the clients indicated having their partner 
present, 21 percent had their friends present when the drug was taken 
and only three percent of clients who took the Misoprostol outside the 
health facility had their mother present when they took the medication. 
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About three in ten (28.7 percent) clients indicated they experienced the 
onset of expulsion after taking Mediprist. Complete expulsion usually 
happened within the first 6 hours after taking the second medication, 
Misoprostol. About 80 percent experienced complete expulsion within 
the first 24 hours after administering Misoprostol as shown in Table 6. 
Approximately two percent needed an additional dose of Misoprostol 
for complete expulsion. About 9 clients did not experience any 
expulsion after taking the medication and had surgical completion at 
no cost to them. This conforms with other studies that have shown 
that generally under 5% of women who go in for medical abortion do 
not experience any expulsion and would need a suction procedure to 
complete it (Spitz et. al, 1998). The success rate in this study is quite 
high and could be explained by the relatively low gestational age cap.




Table 5: Person Present during Administration of Misoprostol 
 
Responses 
 Person Present Number Percent 
A husband/boyfriend 43 60.6 
A friend  15 21.1 
Mother  2 2.8 
Other relatives 6 8.5 
Others 6 7.0 
Total 72 100.0 
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Table 6: Time Taken for Complete Expulsion after Misoprostol 
Length of Time Number Percent 
Less than 6 hours 186 40.3 
Between 6-12 hours 100 21.7 
Between 12-24 hours 84 18.2 
More than 24 hours 75 16.3 
Needed additional dose of misoprostol 7 1.5 
Fetus was never expelled 9 2.0 
Total 461 100.0 
 
Known Side Effects of Medical Abortion 
 
Vomiting was the most mentioned side effect of both Mediprist and Misoprostol medication as 
shown in Tables 8 and 9. This was followed by dizziness, headaches, and diarrhea after taking 
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Known Side Effects of Medical Abortion
Vomiting was the least mentioned side effect of both Mediprist and 
Misoprostol medication as shown in Tables 7 and 8. As expected, most 
clients experienced cramps/pain  after taking Misoprostol.  
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Clients had very varying experiences with side-effects; the most mentioned side-effect 
experienced by clients after taking just the Mediprest was cramps/pain for which they 
generally took pain medication. After taking the second medication Misoprostol, the clients 
reported that nausea was the most mentioned side effect experienced; this is most likely an 
effect of the combination of the two medications.  The majority of the clients (77.8 percent) 
reported that they did not feel any effects or changes in their body function which can be 
linked to the medication or abortion at the time of the study. 
 
  Responses 
Side Effects of  Mediprist Number Percent 
Cramps/pain  218 47.3 
Bleeding  137 29.7 
Nausea  98 21.3 
Chills  89 19.3 
Flushes/sweats  86 18.7 
Diarrhea  86 18.7 
Headaches  85 18.4 
Dizziness  77 16.7 
Vomiting  62 13.4 
   
  Client Responses 
Side Effects of Misoprostol Number Percent 
Bleeding  432 93.7 
Cramps/pain  415 90.0 
Chills  151 32.8 
Diarrhea  148 32.1 
Headaches  144 31.2 
Flushes/sweats  128 27.8 
Dizziness  115 24.9 
Nausea  104 26.6 
Vomiting  80 17.4 
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Cramps/pain  218 47.3 
Bleeding  137 29.7 
Nausea  98 21.3 
Chills  89 19.3 
Flushes/sweats  86 18.7 
Diarrhea  86 18.7 
Headaches  85 18.4 
Dizziness  77 16.7 
Vomiting  62 13.4 
   
  Client Responses 
Side Effects of Misoprostol Number Percent 
Bleeding  432 93.7 
Cramps/pain  415 90.0 
Chills  151 32.8 
Diarrhea  48 2.1 
Headaches  4 1.2 
Flushes/sweats  28 27.8 
Dizzine s  15 4.9 
Nausea  04 6.6 
Vomiting  80 17.4 
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Clients had very varying experiences with side-effects; the most 
mentioned side-effect experienced by clients after taking just the 
Mediprist was cramps/pain for which they generally took pain 
medication. After taking the second medication Misoprostol, the clients 
reported that nausea was the most mentioned side effect experienced; 
this is most likely an effect of the combination of the two medications. 
The majority of the clients (77.8 percent) reported that they did not feel 
any effects or changes in their body function which can be linked to the 
medication or abortion at the time of the study.
Service Providers’ Training and Knowledge about Medical 
Abortion
It is essential that service providers are knowledgeable about the 
services they provide as this allows them to provide the services 
more professionally which will result in high acceptance and high 
satisfaction. All the interviewed providers are health professionals 
with the following technical qualification distribution: 10 midwives, 
2 nurses and 1 medical assistant. The average number of years’ service 
providers had worked in their respective health facilities at the time of 
the study was 6 years with highest being 17 years and the least, 1 year. 
All interviewed service providers had received training to provide 
medical abortion services from at least one of the following 
organizations; Ipas, Marie Stopes International Ghana, and Gynuity in 
collaboration with Ghana Health Service between 2005 and 2009. The 
average number of years providers had been introduced to medical 
abortion is 4 years with a maximum of 9 years and a minimum of 
less than a year. There have been in previous years a few small-scale 
medical abortion studies mainly based in single facilities which some 
of the providers were exposed to, these have all been one-off, short 
period studies.
 
To ascertain the confidence level of providers in the provision of the MA 
services they were asked to rank their knowledge and understanding 
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on the administration of the MA medication. A significant proportion 
of providers; 92.4 percent ranked themselves as having excellent and 
very good knowledge on the administration of MA medication. As 
shown in Table 9 only 7.6 percent ranked themselves as having good 
knowledge about the drug administration procedure. None ranked 
themselves as having poor knowledge. This corresponds with the 
percentage of providers who knew the accurate dosage of Mediprist. 
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medication. A significant proportion of providers; 92.4 percent ranked themselves as having 
excellent and very good knowledge on the administration of MA medication. As shown on 
Table 10 only 7.6 percent ranked themselves as having good knowledge about the drug 
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Almost all (92.3 percent) service providers knew the accurate and recommended dosage of 
Mediprist per case (200mg).  Providers were asked about the ineligibility criteria for medical 
abortion service. As shown in Table 11, the most mentioned was history of allergy to 
prostaglandin, followed by chronic renal failure and confirmed or suspected ectopic 
pregnancy.  Other ineligibility criteria mentioned were concurrent long-term corticosteroid 
therapy, hemorrhagic disorders or concurrent anticoagulant therapy and the least mentioned 
criteria was inherited porphyries. 
 
 
  Client Responses 
Knowledge about drug 
administration        Percent 
Excellent  46.2 




Almost all (92.3 percent) service provid rs knew the accurate and 
recommended dosage of Mediprist per case (200mg).  Providers were 
asked about the ineligibility criteria for medical abortion service. 
As shown in Table 10, the most mentioned was history of allergy to 
prostaglandin, followed by chronic renal failure and confirmed or 
suspected ectopic pregnancy.  Other ineligibility criteria mentioned 
were concurrent long-term corticosteroid therapy, hemorrhagic 
disorders or concurrent anticoagulant therapy and the least mentioned 
criteria was inherited porphyries.
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Table 10: Service Provider Knowledge of Ineligibility Criteria for Mediprist 
Ineligibility criteria  Responses  Number Percent 
History of allergy to prostaglandin  7 53.8  
Confirmed or suspected ectopic pregnancy  6 46.2  
Chronic renal failure  6 46.2  
 Concurrent long-term corticosteroid therapy 4 30.8  
Hemorrhagic disorders or concurrent anticoagulant therapy  3 23.1  
Inherited porphyries  1 7.7  
    
 
 
Satisfaction and Acceptance of Medical Abortion 
 
The acceptance of a new intervention in a general population depends significantly on the 
level of satisfaction experienced by initial users. Aggregated levels of satisfaction generally 
give a more accurate level of satisfaction among the general population.  
 
The level of satisfaction derived from the medical abortion service was measured by both 
client and provider satisfaction. Providers of reproductive health care services including 
medical abortion services are a critical component in the successful introduction and 
implementation of any health intervention policy, program or product. Their satisfaction, 
comfort and acceptance of a product and/or a service allows for better provider-client 
interaction generally leading to higher client satisfaction rates. In the case of providers, about 
11 out of the 13 providers indicated that they were satisfied with the product, the other two 
providers felt they were not entirely certain of the efficacy of the medication, however almost 
all (12 out of 13) the service providers were of the opinion that clients were satisfied with the 
product. This shows the level of acceptance of the product by service producers which will be 
pivotal in scaling up of the program to a larger population.  
 
As can be seen from Table 12, about 94 percent of the clients were satisfied with the 
medication abortion procedure. However, about 4 percent were indifferent and about 3 
percent were not satisfied with the medical abortion procedure. 
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The acceptance of a new intervention in a general population depends 
significantly on the level of satisfaction experienced by initial users. 
Aggregated levels of satisfaction generally give a more accurate level of 
satisfaction among the general population. 
The level of satisfaction derived from the medical abortion service 
was measured by both client and provider satisfaction. Providers 
of reproductive health care services including medical abortion 
services are a critical component in the successful introduction and 
implementation of any health intervention policy, program or product. 
Their satisfaction, comfort and acceptance of a product and/or a service 
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client satisfaction rates. In the case of providers, about 11 out of the 13 
providers indicated that they were satisfied with the product, the other 
two providers felt they were not entirely certain of the efficacy of the 
medication, however almost all (12 out of 13) the service providers were 
of the opinion that clients were satisfied with the product. This shows 
the level of acceptance of the product by service producers which will 
be pivotal in scaling up of the program to a larger population. 
As can be seen from Table 11, about 94 percent of the clients were 
satisfied with the medication abortion procedure. However, about 4 






Table 11: Percent Distribution of Clients by Level of Satisfaction 
 
      Responses 
 Levels Number Percent  
Very Satisfactory 201 43.6  
Satisfactory 230 49.9  
Indifferent 17 3.7  
Unsatisfactory 5 1.1  
Very Unsatisfactory 8 1.7  
Total 461 100  
 
 
The level of client’s satisfaction with the medical abortion procedure was translated in their 
confirmation that they would recommend the procedure to other friends, family and relations 
as well as choosing the procedure again in the future should it become necessary. About four 
in five (82.9 percent) clients indicated they will select the method again, while about 90.0 
percent indicated that they will recommend the method to their family and friends.  
 
Difficulties and Challenges of Medical Abortion in Ghana 
 
The most mentioned challenge associated with the provision of medical abortion as reported 
by the providers is the persistent calls they received from clients.  According to the providers, 
there is an associated level of uncertainty because they usually cannot tell exactly the severity 
of what really is happening to the client. Some providers also indicated that, for a few clients 
(about 7 clients), there was a need to repeat the Misoprostol which they were not very 
comfortable in administering. Finally, one provider indicated that failure to get call back from 
clients who took the medication home is usually disturbing because one cannot tell what 




Table 12: Provider Challenges Associated with Medical Abortion 
 
Responses 
 Challenges Number Percent  
No challenges 7 53.8  
Persistent calls from client 3 23.1  
Additional dose of Misoprostol 2 15.4  
No call back because client took drug home 1 7.7  
Total 13 100  
 
 
Clients on the other hand had varying experiences during medical abortion process. 
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Clients on the other hand had varying experiences during medical abortion process. 
Abdominal pains and/or waist pains were the most mentioned worst experiences associated 
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The level of client’s satisfaction with the medical abortion procedure 
was translated in their confirmation that they would recommend the 
procedure to other friends, family and relations as well as choosing 
the procedure again in the future should it become necessary. About 
four in five (82.9 percent) clients indicated they will select the method 
again, while about 90.0 percent indicated that they will recommend 
the method to their family and friends. 
Difficulties and Challenges of Medical Abortion in Ghana
The most mentioned challenge associated with the provision of 
medical abortion as reported by the providers is the persistent calls 
they received from clients.  According to the providers, there is an 
associated level of uncertainty because they usually cannot tell exactly 
the severity of what really is happening to the client. Some providers 
also indicated that, for a few clients (about 7 clients), there was a need 
to repeat the Misoprostol which they were not very comfortable in 
administering. Finally, one provider indicated that failure to get call 
back from clients who took the medication home is usually disturbing 
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Clients on the other hand had varyi g experiences during medical 
bortion pr cess. Abdominal pains and/or waist pains w e the most 
mentioned worst experiences associated with the procedure. This was 




with the procedure. This was followed by abdominal cramps and excessive 
bleeding/discharge. 
 
Table 13: Distribution of Worst Experience by Clients 
 
Client’s Responses 
 Worst Experience Number Percent 
 Abdominal pains or waist pains 185 32.3  
Abdominal cramps 99 17.3  
Excessive bleeding / Discharge 79 13.8  
No side effect 18 3.1  
Vomiting 17 3.0  
Bleeding 15 2.6  
Uncomfortable 13 2.3  
Nausea 12 2.1  
Very painful like during labor 12 2.1 
 Severe chills / offensive odor / feverishness 11 1.9 
 Pregnancy not completely terminated 9 1.6 
 Weakness in my legs and joints 8 1.4 
 Headaches 8 1.4 
 Diarrhea 6 1.0  
Extra money spent for pads 6 1.0  
Severe menstrual pains 4 0.7 
 Needed additional dose for a complete expulsion 4 0.7 
 Surgical method needed for completion 4 0.7 
 Loss of appetite 2 0.3 
 Discharge of blood clots 1 0.2 
 Had no significant side effect 28 4.9  
 
 
The best experience of the entire process according to the clients was the expulsion of 
product of conception within a short time. They also indicated that the procedure was very 
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The best exp ce of the entire process according to the clients was 
the expulsion of product of conception within a short time. They also 
indicated that the procedure was very effective and for some of them, 








 Best Experience Number Percent 
 Had an expulsion of the fetus within short time 148 29.2  
Bleeding was just like normal menstrual flow 77 15.2  
It was very effective 59 11.6  
Medication was easily taken 43 8.5  
Happy about the complete abortion 28 5.5  
Affordable 21 4.1  
Ensures more privacy 11 2.2  
Nothing was good about this procedure 9 1.8  
To avoid surgical method 6 1.2  
Can do the insertion yourself 6 1.2  
More effective than Misoprostol alone therapy 6 1.2  
Avoided any physical trauma / pains 5 1.0  
Checked and  monitored by health providers 5 1.0  
Pain was just for a short while 4 0.8  
Coming to the facility to have it done 3 0.6  
Severe abdominal cramps 2 0.4  
The provider was always nice to me 2 0.4  
No side effect / No complication 26 5.1  
 
 
Scaling up and Sustainability of Program and Product Services 
 
Scaling up and sustaining the program will depend on availability of the products and 
affordability of the service. Same as charges for MVA services, an average price of GH¢40 
was mentioned by service providers from both the private and public sector as the 
recommended amount clients should pay for the service. As shown in table 16, to ensure that 
more women have access to this life saving procedure, more than fifty percent of the 
interviewed service providers recommend that there should be intense counseling and 
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The principal focus of this documentation study is multifold. It 
concerns the perception, acceptance of the methods by clients who opt 
for it. It also documents from the client’s perspective, acceptability, side 
effects associated with the method, and finally from providers, comfort 
in the provision of the service. The study further examined the skills 
and quality of service providers of medical abortion offered to their 
clients. The mean age of the clients was 25.8 years with 13.2% of them 
in their teen ages. The majority of them (55%) had never married; 
the average number of children ever born (life birth) is one while the 
average number of pregnancy experienced is about three.  
Providers took clients through counseling and allowed clients to 
choose a method, approximately 93 percent of the clients reported 
that providers gave them sufficient information on methods during 
their first counseling consultation.  It is also important to note that, 
about 50 percent of the clients had medical abortion in mind before 
visiting the facility, whiles about 48 percent had MVA/EVA in mind. 
Among the clients who took the Misoprostol at home, about 78 
percent of them reported that they preferred to be alone during the 
drug administration. This reinforces the notion that typically, women 
who go in for an abortion would not want it to be known to others. 
This also highlights the fact that due to the high stigmatization of the 
procedure, nobody wants to be publicly associated with abortion. 
Acceptability of medical abortion was very high, about 81 percent of 
the clients indicated that they will use the method again if they had to, 
while 89.5 percent indicated that they will recommend the method to 
their friends, approximately 85 percent of the providers were satisfied 
with the product.
The most noted side effect of  Misoprostol was cramping. Among those 
who reported of side effect from the medical abortion process, 62.9 
percent required some pain medication and treatment.  Approximately 
78 percent of the clients did not feel any effect or changes in their body 
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as a result of medical abortion at the time of the study.  Whiles more 
than 80 percent of the clients’ experienced complete expulsion within 
24 hours after administration of Misoprostol, about 16 percent had 
their expulsion after 24 hours with two percent needing additional 
dose and two percent needing a surgical completion.
Although the study showed high satisfaction with the method from 
clients and providers, the study identified one major challenge which 
needs to be addressed. This challenge has to do with getting clients to 
return to the facility for a follow-up visit where they would be examined 
to ascertain complete expulsion. Counseling should be intensified such 
that clients will feel the importance in them returning to the facility for 
a follow-up visit. 
There are several advantages and disadvantages to either the surgical 
or medical abortion. The major advantage that the medical abortion 
has over the surgical is that the risk of surgery and use of anesthesia is 
avoided and the medical abortion procedure is generally less painful. 
The main disadvantages of medication over surgical abortion is that 
the duration for completion of the process is longer and is generally 
not recommended after a certain gestation period.
Overall the study has shown that medical abortion is a viable option 
for Ghanaian women, an overwhelming number of those who have 
benefitted from the procedure are content and will use or recommend 
it. The report shows that in Ghana, the women who used the procedure 
had no life threatening side effects at the time of their review visit. Most 
of the women interviewed reported headaches and cramps which are 
well known and documented side effects. Based on the findings of this 
report, it is highly recommended that more providers get trained in 
the provision of the service and most importantly the complementary 
counseling that it requires. The products and service should be made 
easily accessible and available to all women especially the vulnerable 
in order to stem the mortality rates associated with unsafe abortion. 
This study has shown that medical abortion is an effective method for 
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first trimester up to 56 days of amenorrhea abortion; however medical 
abortion should not be viewed as a replacement but rather an alternative 
to surgical abortion. 
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Table 15: Study Sample by Socio-Demographic Characteristics 
Socio-demographic characteristics Percent Number 
Age group 
     15-19 13.2 63 
20-24 32.3 154 
25-29 30.6 146 
30-34 14.5 69 
35-39 6.3 30 
40-44 3.1 15 
   Marital Status 
     Never married 55.0 262 
Married 26.3 125 
Cohabiting 15.8 75 
Widowed 0.4 2 
Divorced 1.5 7 
Separated 1.1 5 
   Highest Level of Education 
  No schooling 6.3 30 
Primary 11.1 53 
Middle/JSS/JHS 27.1 129 
Sec/SSS/Tec/Vocational 35.1 167 
Higher 20.4 97 
   Religion 
  Christianity 89.5 426 
Islam 8.6 41 
Traditionalist 0.2 1 
No religion 1.3 6 
Other 0.4 2 
   Ethnicity 
  Akan 49.2 232 
Ewe 16.7 79 
Ga-Dangme 19.1 90 
Mole Dagbani 10.2 48 
Guan 2.8 13 
Other 2.1 10 
   Main Occupation 
  Housewife 2.1 10 
Agricultural worker 0.2 1 
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Professional/Clerical/Technical 26.5 126 
29 
 
Trading/Vending for employer 5.5 26 
Trading/Vending for oneself 22.3 106 
Apprentic  6.9 33 
Student 23.6 1 2 
Unempl yed 11.2 53 
Other 1.7 8 
 
 
